期刊文献+

恶性肿瘤的代谢与免疫逃逸

Tumor cell metabolism and tumor immune escape
下载PDF
导出
摘要 恶性肿瘤的发生发展意味着肿瘤细胞适应了不利的环境。肿瘤细胞代谢往往降低线粒体活性和氧化磷酸化过程,在很大程度上依赖有氧糖酵解产生能量。这特定的新陈代谢造成肿瘤微环境的变化,帮助肿瘤细胞得以生存、转移及免疫逃逸,而免疫逃逸包括抑制和阻断肿瘤的免疫反应。这一效应通过许多机制实现,包括肿瘤代谢过程及代谢产物对免疫系统直接和间接的抑制和阻断作用。 Tumorigenesis implies adaptation of tumor cells to an adverse environment. Tumor cell metabolism tends to avoid mitochondrialactivity and oxidative phosphorylation( OXPHOS),and largely relies on glycolysis to produceto avoid mitochondrialactivity and oxidative phosphorylation( OXPHOS),and largely relies on glycolysis to produce en-ergy. The metabolism result in modificationof the tumor microenvironment,help tumor cells survive,transfer and im-mune escape,and immune escapeincludblockor avoidtumor immune response. This effect is achieved through a number of mechanisms,whichincludeimmunosuppression from tumor metabolism and metabolic products.
出处 《现代肿瘤医学》 CAS 2014年第10期2510-2514,共5页 Journal of Modern Oncology
基金 山东省科技发展计划(编号:2012YD18116)
关键词 Warburg效应 肿瘤微环境 免疫逃逸 Warburg effect tumor microenvironment immune escape
  • 相关文献

参考文献52

  • 1Villalba M,Rathore MG,Lopez - Royuela N, et al. From tumor cellmetabolism to tumor immune escape[ J]. Int J Biochem Cell Biol,2013,45(1):106-113.
  • 2Warburg 0. On respiratory impairment in cancer cells[ J]. Science,1956,124(3215):269 -270.
  • 3Carracedo A, Weiss D, Leliaert AK,et al. A metabolic prosurvivalrole for PML in breast cancer [ J ]. J Clin Invest, 2012,122 ( 9 ):3088 -3100.
  • 4Yaromina A,Quennet V,Zips D,et al. Co - localisation of hypoxiaand perfusion markers with parameters of glucose metabolism in hu-man squamous cell carcinoma(hSCC) xenografts [ J]. Int J RadiatBiol,2009,85(11) :972 -980.
  • 5Gottfried E,Kunz - Schughart LA,Ebner S,et al. Tumor - derivedlactic acidmodulates dendritic cell activationand antigen expression[J]. Blood,2006,107(5):2013 -2021.
  • 6Kong HS,Lee S,Beebe K. Emetine promotes von Hippel - Lindau-independent degradation of hypoxia - inducible factor - 2a inclear cell renal carcinoma [ J]. Mol Pharmacol,2010,78(6) : 1072-1078.
  • 7Semenza GL. Defining the role of hypoxia - inducible factor 1 incancer biology and therapeutics[ J]. Oncogene,2010,29(5) :625-634.
  • 8Kareva I,Hahnfeldt P. The emerging ” hallmarks” of metabolic re-programming and immune evasion : Distinct or linked [ J ] . CancerRes,2013,73(9) :2737 -2742.
  • 9Mazurek S,Zwerschke W,Jansen - Durr P,et al. Metabolic cooper-ation between different oncogenes during cell transformation : Inter-action between activated ras and HPV - 16E7 [ J ]. Oncogene,2001,20(47) :6891 -6898.
  • 10Delmastro - Greenwood MM,Piganelli JD. Changing the energy ofan immune response[ J]. Am J Clin Exp Immunol,2013,2(1):30 -54.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部